2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow URLC10: new trials by email Literature Review of URLC10 trials Research Report on URLC10
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer HLA-A*0201 or HLA-A*0206-restricted URLC10 peptides - Non-small Cell Lung Cancer | Phase 1 | Completed | Shiga University | 9 | 2010-02-01 | 2019-03-19 |
| Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer URLC10 - Esophageal Cancer | Phase 1 | Completed | Kinki University | 7 | 2006-11-01 | 2012-04-06 |
Carcinoma, Non-Small-Cell Lung (1) · Esophageal Neoplasms (1) · Lung Neoplasms (1)
Kinki University (1) · Shiga University (1)
Japan (2)